TrialCell reports. Medicine2025

Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma.

Yu-Tong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.